Standard Biotools | FLDM - Des Atouts





Des Atouts Changement Date
Agilent USD 13.07B 252M 2026-03
Becton, Dickinson and Co. USD 50.83B 4.01B 2026-03
Bio-Rad Laboratories USD 9.79B 786.5M 2026-03
Bruker USD 6.13B 110.7M 2026-03
Danaher USD 83.54B 80M 2026-03
Illumina USD 6.56B 85M 2026-03
Myriad Genetics USD 673.7M 32.9M 2026-03
Nikon Corporation JPY 1.08T 24.82B 2026-03
Pacific Biosciences Of California USD 782.36M 1.72M 2026-03
Revvity USD 12B 171.82M 2026-03
Roche Holding CHF 100.7B 5.94B 2025-12
Sony JPY 15.68T 201.48B 2026-03
Standard Biotools USD 639.11M 71.36M 2026-03
Thermo Fisher Scientific USD 113.28B 2.94B 2026-03
Waters USD 24.53B 19.45B 2026-03